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ATP-SENSITIVE POTASSIUM CHANNEL SUBCELLULAR TRAFFICKING 
DURING ISCHEMIA, REPERFUSION, AND PRECONDITIONING 
 
JOANNE CIN-YEE HO 
ABSTRACT 
 Ischemic preconditioning is an endogenous cardioprotective mechanism in 
which short periods of ischemia and reperfusion provide protection when given 
before a subsequent ischemic event. Early mechanistic studies showed ATP-
sensitive potassium (KATP) channels to play an important role in ischemic 
preconditioning. KATP channels link intracellular energy metabolism to membrane 
excitability and contractility. It is thought that KATP channels provide a 
cardioprotective role during ischemia by inducing action potential shortening, 
reducing an excessive Ca2+ influx, and by preventing arrhythmias. However, the 
mechanisms by which KATP channels protect during ischemic preconditioning are 
not known. In this study, we investigated a novel potential mechanism in which 
alterations in subcellular KATP channel trafficking during ischemia and ischemic 
preconditioning may result in altered levels of surface channel density, and 
therefore, a greater degree of cardioprotection.  
In the optimization of our experiments, we compared various antibodies 
for their specificity and sensitivity for channel subunit detection in 
immunoblotting. In addition, we examined the effects of varying salt 
concentrations during tissue homogenization in order to determine the optimal 
conditions for protein isolation. Furthermore, we examined the effect of heating 
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the samples prior to SDS-PAGE for improved detection of channel proteins by 
immunoblotting.  
The subcellular trafficking of some membrane proteins is altered by 
ischemia. For example, the glucose transporter, Glut4, translocates from 
endosomal compartments to the sarcolemma (Sun, Nguyen, DeGrado, 
Schwaiger, & Brosius, 1994). Conflicting data exists regarding the effects of 
ischemia on KATP channel subcellular trafficking and the regulation of KATP 
channel surface density (Edwards et al., 2009 and Bao, Hadjiolova, Coetzee, & 
Rindler, 2011). We therefore, sought to test our hypothesis that KATP channels 
are internalized from the surface of cardiomyocytes to endosomal compartments 
during ischemia, and this internalization can be reduced and/or reversed by 
ischemic preconditioning. We subjected isolated Langendorff-perfused mouse 
hearts to ischemia, reperfusion, or ischemic preconditioning events and 
measured the density of KATP channels in the sarcolemmal and endosomal 
compartments. We also determined the degree of injury by staining heart slices 
with triphenyltetrazolium chloride and compared infarct sizes between hearts 
subjected to ischemia and ischemic preconditioning. 
Our data demonstrated that KATP channels are, in fact, internalized during 
ischemia and that reperfusion led to a slow recovery of surface KATP channel 
density. Interestingly, ischemic preconditioning reduced the size of infarcts 
induced by ischemia and also prevented the ischemia-induced decrease of KATP 
channel surface density, thereby, contributing to cardioprotection. 
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INTRODUCTION 
 Heart disease is the leading cause of death in the United States for both 
men and women. Myocardial ischemia, a type of coronary heart disease, can 
result in myocardial infarction and is one of the leading causes of death in the 
United States (Go et al., 2012). These alarming statistics demonstrate the 
importance of furthering our understanding of the mechanisms involved in the 
development, progression, and treatment of coronary heart disease.  
 Myocardial ischemia occurs when an occlusion of the coronary artery 
reduces blood flow such that insufficient oxygen and nutrients are delivered to 
the myocardium. This leads to accelerated cardiomyocyte death and causes 
permanent injury to the heart muscle. Several consequences of myocardial 
ischemia include myocyte damage which triggers necrosis, autophagy, and 
apoptosis leading to infarction (Luther, Thodeti, & Meszaros, 2013). Additionally, 
arrhythmias can be caused by ischemia (Cascio, Yang, Muller-Borer, & Johnson, 
2005). Reperfusion of blood and oxygen to the site of occlusion is possible after 
myocardial ischemia, by spontaneous opening of the coronary vessel or by 
induced reopening by angioplasty interventions.  
Ischemic Preconditioning 
 Ischemic preconditioning (IPC) is an innate form of protection against the 
damage caused by myocardial ischemia. IPC occurs when brief intervals of 
induced sub-lethal ischemia, separated by brief intervals of reperfusion, precede 
a prolonged period of ischemia (Murry, Jennings, & Reimer, 1986). In an early 
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study, IPC reduced the ischemia induced infarct size from 30% of the heart to 7% 
and also delayed cell death (Murry et al., 1986). IPC is also protective against the 
loss of ventricular function (Murry et al., 1986) and against the development of 
arrhythmias (Shiki & Hearse, 1987).   
Mechanisms of IPC 
 Initially, IPC was shown to reduce energy metabolism by washing out 
ischemic catabolites with each reperfusion period (Murry et al., 1986). Another 
mechanism by which IPC may be cardioprotective is by reducing calcium 
overload in the heart, which would otherwise cause a quick depletion of ATP 
(Murphy & Steenbergen, 2008). Opening of sarcolemmal KATP channels during 
ischemia may lessen cytosolic calcium (Ca2+) load to conserve ATP consumption 
(due to the negative inotropic effect; the “energy sparing hypothesis”) and 
prevent Ca2+-induced mitochondrial dysfunction (Storey, Stratton, Rainbow, 
Standen, & Lodwick, 2013). Preventing Ca2+ accumulation may also directly 
lessen Ca2+-mediated necrosis. These observations suggest that opening of KATP 
channels may have a similar beneficial effect compared to IPC. Several studies 
have implicated the KATP channels as a player in the coupling mechanism by 
which preconditioning occurs (Jerome, Akimitsu, Gute, & Korthuis, 1995 and 
Schultz, Qian, Gross, & Kukreja, 1997). In one of these studies, the blockage of 
KATP channels with glibenclamide—a KATP channel antagonist—prevented IPC’s 
protective effect. Furthermore, several studies have also demonstrated that KATP 
channel openers, when given before an ischemic event, can mimic the protective 
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effect of IPC (Grover, 1997). Taken together these studies suggest that KATP 
channels have an important endogenous cardioprotective role (G J Gross & 
Auchampach, 1992). However, the precise mechanisms by which KATP channels 
participate in IPC-induced cardioprotection are currently unknown. Our data will 
demonstrate a novel mechanism that involves KATP channel subcellular 
trafficking. 
ATP-Sensitive Potassium Channels 
 KATP channels were first discovered in the cells of the heart and were later 
found to be present in numerous other tissues throughout the body (Noma, 
1983). They play an essential role in coupling the changes in cellular energy 
metabolism to altered electrical excitability (Ashcroft, 1988). KATP channels are 
opened by increased levels of intracellular nucleoside diphosphates, MgADP in 
particular, and are inhibited by increased levels of intracellular ATP (Findlay, 
1988 and Lederer & Nichols, 1989). Thus, under ischemic or hypoxic conditions, 
when cellular ATP levels decrease and ADP levels increase, the KATP channel 
open probability increases. When the KATP channel opens, there is a controlled 
outward flux of potassium out of the cell, and the resulting outward current 
causes a reduction in the action potential duration and prevents calcium 
accumulation in the cell.  
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Structure and Function of KATP Channel 
 KATP channels are heteroctameric complexes composed of two different 
proteins, the sulfonylurea receptors (SURx), which belong to the ATP binding 
cassette (ABC) family, and the inward-rectifying potassium ion channel (Kir6.x) 
subunit (Nichols, 2006). Kir6.x subunits are coded by the Kcnj8 gene (Kir6.1) and 
Kcnj11 gene (Kir6.2). The Kir6.x proteins make up the pore forming subunit of 
the channel and determine its biophysical properties. There are three functionally 
relevant forms of the sulfonylurea receptors, SUR1, SUR2A, and SUR2B which 
determine nucleotide and pharmacological sensitivity of the channel (Inagaki et 
al., 1996). 
The Kir6.x subunit tetramerize to form the channel pore and each is linked 
to a SURx subunit, altogether forming an octameric complex (Seino & Miki, 
2003). Co-expression of different Kir6.x/SURx combinations lead to the formation 
of KATP channels with distinct electrophysiological and pharmacological 
properties (Babenko, Gonzalez, Aguilar-Bryan, & Bryan, 1998). There is a 
requirement for co-expression of Kir6.x and SURx in order to form a functional 
channel. This requirement is due to the presence of an endoplasmic reticulum 
retention sequence that is present in both Kir6.x and SURx subunits (Zerangue, 
Schwappach, Jan, & Jan, 1999). When SURx or Kir6.x subunits are expressed 
individually, they cannot traffic to the cellular membrane, as they contain an 
endoplasmic reticulum retention sequence (Zerangue et al., 1999).  
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ATP blocks channel function by directly interacting with the Kir6.x subunit 
(Tucker, Gribble, Zhao, Trapp, & Ashcroft, 1997). In contrast, MgADP activates 
the KATP channel by binding to SURx. Specifically, MgADP binds to cytoplasmic 
nucleotide binding folds (NBF1 and NBF2), present in SURx (Seino & Miki, 
2003). The SURx subunits also determine the pharmacological profile of the KATP 
channel. A known powerful blocker of KATP channels is glibenclamide, clinically 
used as an antidiabetic drug, which binds to the SURx subunit and blocks KATP 
channel activity (Aittoniemi et al., 2009). KATP channel openers, such as pinacidil 
and diazoxide, also target the SUR subunits (Aittoniemi et al., 2009).  
KATP Channels Protect the Heart from Ischemic Damages 
 KATP channels are particularly significant to the cardiovascular system as 
they have been linked to cardioprotection against ischemia (Grover, 1994). There 
is strong evidence that the ventricular KATP channel consists of Kir6.2 and 
SUR2A subunits (Babenko, Aguilar-Bryan, & Bryan, 1998). Through the opening 
of KATP channels, ischemia reduces action potential duration by reducing calcium 
influx and accumulation in heart cells (Lefer, Nichols, & Coetzee, 2009). The 
activation of these channels by ATP depletion during anoxia was confirmed  by 
patch clamp techniques using guinea-pig heart cells (Noma & Shibasaki, 1985).  
Mitochondrial KATP Channels vs. Sarcolemmal KATP Channels 
  Currently there is debate over whether the cardioprotective effects of IPC 
are mediated by sarcolemmal KATP channels (SarcKATP) or mitochondrial KATP 
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channels (MitoKATP). There is clear evidence of a definitive role for SarcKATP 
during IPC (Suzuki et al., 2002) and some evidence does exist suggesting that 
there might be some cardioprotection from MitoKATP channels (Light, Kanji, Fox, 
& French, 2001). Additionally, it is possible both the SarcKATP channels and the 
MitoKATP channels are involved in IPC for cardioprotection (Garrett J. Gross & 
Fryer, 1999). No alterations in mitochondrial function was found in Kir6.2 
knockout mice but there was a loss of protection from ischemic preconditioning 
(Gumina et al., 2003 and Wojtovich et al., 2013). For our studies, we have 
chosen to focus on SarcKATP channels because there is significant evidence that 
they play a role in IPC whereas this role has not been as clearly defined for 
MitoKATP channels.     
Endocytic Recycling 
 Cells are able to internalize ligands or proteins via endocytosis and traffic 
these materials back to the plasma membrane in a process known as endocytic 
recycling (Grant & Donaldson, 2009). Endocytic recycling is a rapid process (in 
the order of minutes) and cells may internalize the equivalent of their entire 
surface area up to five times per hour. This occurs either by clathrin-dependent 
endocytosis, in which adaptor proteins recognize specific plasma membrane 
proteins and package them into clathrin-coated vesicles to bring them into the 
cell, or clathrin-independent endocytosis (Grant & Donaldson, 2009). Once inside 
an intracellular vesicle, the endocytosed cargo is delivered to the early 
endosome where it is sorted into one of a variety of different compartments such 
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as the endocytic recycling compartment, late endosome, or the trans Golgi 
network (Repnik, Česen, & Turk, 2013).  
Endocytic Recycling of KATP channels 
Endocytic recycling represents a potentially powerful mechanism for 
regulating the surface density and availability of KATP channels for biological 
reactions. The KATP channel current magnitude (I) is determined by: 
          
Where ‘N’ is the number of channels, ‘i’ is the single channel current, and ‘Po’ is 
the open probability of each channel. Whereas many studies examine changes in 
Po, we have decided to focus on the number of functional channels; which is 
determined by de-novo protein synthesis, protein degradation, and subcellular 
trafficking of the KATP channels subunits.  
KATP Channel Trafficking: Studies in Transfected Cells  
In Xenopus Oocytes transfected with Kir6.2/SUR1 or Kir6.2/SUR2A, KATP 
channels were endocytosed following activation of protein kinase C (PKC) with 
the phorbol ester, PMA (Hu, Huang, Jan, & Jan, 2003). Further evidence that 
KATP channels can be internalized comes from studies demonstrating that 
mutations of Kir6.2 prevented PKC-mediated endocytosis and that KATP channels 
are internalized via a clathrin-mediated endocytosis (Mankouri, Taneja, Smith, 
Ponnambalam, & Sivaprasadarao, 2006). Studies with human embryonic kidney 
(HEK) cells with epitope tagged KATP channel subunits show that KATP channels 
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undergo several rounds of internalization and recycling back to the surface 
(Manna et al., 2010).  
KATP Channel Trafficking: Studies of Native Channels in Cardiac Myocytes  
What happens to trafficking of native KATP channels? One study involving 
guinea-pig cardiomyocytes showed that short periods of hypoxia and 
reoxygenation (a cellular model of IPC), was associated with increased Kir6.2 
subunits to the cell surface, increased KATP channel density, and led to increased 
cellular survival (Budas, Jovanovic, Crawford, & Jovanovic, 2004). In another 
cellular model, it was found that ‘pharmacological preconditioning’ with 
phenylephrine protected isolated ventricular myocytes by increasing recovery of 
contractile activity following metabolic inhibition and increased the magnitude of 
surface KATP current (Turrell, Rodrigo, Norman, Dickens, & Standen, 2011). 
Preconditioning with phenylephrine also increased activation of different forms of 
PKC and AMPK, suggesting that their activation plays a role in recycling KATP 
channels and thereby is cardioprotective. 
KATP Channel Trafficking: Studies in Hearts 
Studies performed with whole heart preparations have further shown that 
KATP channel trafficking occurs during ischemia. One project questioned whether 
gender difference changed the effects of KATP channel trafficking. Male and 
female mice were Langendorff-perfused and subjected to regional ischemia-
reperfusion (I/R) or solely ischemia and then treated with chelerythrine – an 
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antagonist of PKC (Edwards et al., 2009). The study showed that female mice 
tended to have a higher density of sarcolemmal KATP channel and with I/R or 
ischemia only (or with treatment of chelerythrine) the amount of KATP channel 
increased, suggesting that PKC is involved in KATP channel translocation during 
ischemia (Edwards et al., 2009). A study in rat hearts demonstrated that there is 
a pool of endosomal and sarcolemmal KATP channels, and that the KATP channels 
in endosomal compartments translocate to the sarcolemma during ischemia 
(Bao, Hadjiolova, Coetzee, & Rindler, 2011). A recent study shows that CaMKII 
plays an important role in KATP channel activity and that CaMKII activation by 
elevated Ca2+ (e.g. as occurs during ischemia) increases the endocytosis of KATP 
channels by phosphorylating of Kir6.2 (Li et al., 2007).   
Rationale for Proposed Study 
 Conflicting data exists regarding the effects of ischemia on KATP channel 
subcellular trafficking and the regulation of KATP channel surface density. Some 
studies suggest an increase KATP channel density during ischemia, whereas 
other studies suggest that ischemia decreases the amount of surface KATP 
channels. A systematic study is needed to investigate KATP channel endosomal 
and sarcolemmal distribution and the effects of ischemia, reperfusion, and IPC. 
 In order to investigate the discrepancies in KATP channel distribution during 
ischemia, we performed experiments such as Langendorff-perfusion, membrane 
preparation, and immunoblotting to test the hypothesis that KATP channels are 
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trafficked between endosomes and sarcolemma under different simulated 
conditions of ischemia, ischemic preconditioning, and reperfusion.   
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METHODS 
 
Animals  
Wild-type mice (10 to 14 weeks old, C57BL/6 strain, Taconic) were used. 
All animal handling procedures were in accordance with National Institutes of 
Health guidelines and were approved by the Institutional Animal Care and Use 
Committees of New York University School of Medicine.   
Langendorff-Perfusion  
Male mice were injected with heparin and anesthetized with pentobarbital 
sodium. After 20 minutes, mice were sacrificed and hearts were rapidly excised 
into ice-cold Krebs-Henseleit (KH) buffer containing (in mM) 118.5 NaCl, 25 
NaHCO3, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 5 glucose, 0.05 C2H3NaO2, 0.06 
C3H3O3Na, 1 C3H5O3Na, and 1.4 CaCl2. In procedures where adenosine was 
used, 100 μM of adenosine was added to the KH buffer. After removal of the lung 
and surrounding tissues, the aorta was rapidly cannulated with a blunted 21 
gauge hypodermic needle and tied off with size 4.0 surgical silk. Then hearts 
were continuously perfused with KH solution, equilibrated with 95% O2/5% CO2 
at a constant perfusion pressure of 80 mmHg (100 cm H2O) and a constant 
temperature of 37oC. No-flow ischemia was induced by clamping off the tube that 
perfused the aorta, while hearts were submerged in KH solution at 37oC. After 
the ischemic period, the hearts were immediately placed in liquid nitrogen and 
kept at -80oC until they were used for membrane preparation. Alternatively, they 
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were wrapped in clear Saran wrap and stored at -20oC for up to an hour before 
being TTC stained to measure infarct sizes (see later). Standard experimental 
perfusion protocols are shown in Table 1. 
Conditions Times 
Control 75 min 
Ischemia 45 min stabilization 
30 min ischemia 
IPC 15 min stabilization 
5 min ischemia + 5 min reperfusion (x3) 
30 min ischemia 
 
Table 1. Reperfusion Protocol 
Times of standard ischemia, reperfusion, and IPC times used in our experiments. 
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Crude Membrane Preparation  
 Our technique for homogenization of the heart tissue has been modified 
from Suárez et al., 2001. We first homogenized frozen mouse heart tissue in 
homogenization buffer (HB) containing (in mM) 250 sucrose, 2 EGTA, 20 
HEPES. The HB solution also contained 1x cOmplete protease inhibitor cocktail 
tablet (Roche, Cat.# 04693116001), 52 μg/ml PMSF and was adjusted to a pH to 
7.4 using NaOH. We used approximately 2.5 ml homogenization buffer per 
mouse heart. The heart was homogenized using a Polytron homogenizer before 
transferring the cell suspension into a tight fit Dounce homogenizer. Cells were 
homogenized on ice with the Dounce homogenizer by 25 strokes. The 
homogenate was then centrifuged at 4000g for 10 minutes at 4oC, and the 
supernatant was transferred into ultracentrifuge tubes and centrifuged at 
190,000g for 1 hour at 4oC. This resulted in a supernatant that corresponded to 
the cytosolic compartment of the cell and the resulting pellet corresponded to the 
membranes. We resuspended the pellet and solubilized the membrane proteins 
overnight in ice-cold resuspension buffer composed of 20 mM HEPES, 0.5% 
Triton X100, protease inhibitors, at a pH of 7.4. The proteins were either used 
immediately or stored at -80oC for later use.  
Membrane Protein Preparation Using Density Gradient Centrifugation  
 We used a method modified from Sadowski et al., 2006 for membrane 
preparation of proteins. All the following procedures were performed on ice 
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unless otherwise indicated. All solutions were kept on ice before use. The tissue 
was snap-frozen in liquid nitrogen and pulverized under liquid nitrogen with a 
mortar and pestle. The tissue powder was then homogenized in complete 
homogenization medium (HM) containing 250 mM sucrose, 10 mM HEPES, 1 
mM EDTA, 1 mM DTT, 1X cOmplete protease inhibitor cocktail tablet, and pH 
was adjusted to 7.4. About 2 ml of homogenization medium was used per mouse 
and homogenization was carried out using a glass-glass homogenizer for 30 
strokes after the powder has been mixed with the buffer. The tissue homogenate 
was further homogenized in a tight-fitting Dounce homogenizer for 30 more 
strokes. The homogenate was centrifuged at 1000g for 5 minutes at 4oC. The 
supernatant was then placed into an ultracentrifuge tube on ice and the resulting 
pellet was extracted. We further re-homogenized the pellet with fresh complete 
HM using the tight fitting Dounce, homogenizing for 25 strokes and the 
homogenate was centrifuged again (1000g, 5 min, 4oC). The resulting 
supernatant was combined with that of the previous step. The supernatant was 
then used to dilute 60% Optiprep (Sigma Aldrich, Cat.#D1556), with 1mM DTT, 
and protease inhibitors (Optiprep Working Solution – OWS) to 7% Optiprep with 
a final volume of 2ml. One ml of 18% Optiprep (composed of OWS and HM) was 
placed into an ultracentrifuge tube and 2ml of 7% mix was loaded carefully on top 
of the 18% Optiprep. Any remaining homogenate (0% Optiprep) was used to 
overlay the 7% Optiprep and HM was used to bring the tubes to equal weight. 
The tubes were centrifuged at 267,100g using a SW60 rotor (Beckman Coulter, 
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California) for 1 hour at 4oC. A cloudy membrane fraction enriched in plasma 
membrane proteins was formed between the 0% and the 7% layers and it was 
collected with a syringe. Another cloudy membrane fraction was formed between 
the 7% and the 18% layer and was collected with a syringe. This fraction was 
enriched in endosomal proteins. The membrane fractions were diluted with TE 
buffer (containing 10 mM Tris, 1 mM EDTA, and pH to 7.5) up to 1.5 ml volume 
and ultracentrifuged at 370,000g for 15 min at 4oC using the SW60 rotor. The 
resulting supernatant was then discarded and the membrane pellet was 
solubilized in solubilization buffer containing 20 mM HEPES, 0.5% Triton X100 
pH to 7.4. The membrane pellets were solubilized overnight at 4oC under 
rotation. Protein concentrations were measured by Bradford Assay (Bradford, 
1976). 
Western Blotting 
 Western blotting was performed with membrane preparations to detect the 
presence of proteins of interest. All Western blots were performed using 10% 
SDS-PAGE gels. Unless otherwise specified, protein samples were not boiled 
prior to gel loading. Protein samples were mixed with Lithium Dodecyl Sulfate 
Sample Buffer (at a final concentration of 1x) (Thermo Scientific, Prod.#84788) 
and DTT (at a final concentration of 200mM). The gels were then loaded with 
equal amounts of protein as determined by the Bradford Assay and were 
separated by molecular weight using gel electrophoresis. The running buffer was 
composed of 1x Tris/Glycine buffer (Bio-Rad, Cat.#161-0771) with 10% SDS 
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added. A constant voltage of 120V was applied until the proteins traversed the 
length of the gel. Afterwards, the protein samples were transferred onto a 
polyvinylidene difluoride (PVDF) membrane (Bio-Rad, Cat.# 162-0177). First, the 
PVDF membrane was washed in methanol for 5 minutes to increase its 
hydrophilicity. It was then placed in transfer buffer composed of 10x Tris/Glycine 
buffer, SDS, and methanol. Next, the gel and membrane were sandwiched 
between filter paper and sponge and then submerged in transfer buffer. Transfer 
occurred with constant stirring at a constant current of 400 mA for 100 minutes at 
4oC. After transfer, the PVDF membrane was blocked in 5% non-fat dry milk for 1 
hour at room temperature to prevent binding of the antibody to non-specific 
proteins. Following blocking, the PVDF membrane was probed for the protein of 
interest with the appropriate primary antibody diluted in 5% non-fat dry milk 
overnight at 4oC. Then the PVDF membrane was washed a minimum of three 
times at 10 minute intervals in Tris Buffer Saline plus 0.05% Tween (TBST) 
solution. Afterwards, the PVDF membrane was blotted with horseradish 
peroxidase-labelled (HRP) secondary antibody diluted in 5% non-fat dry milk for 
1 hour at room temperature. Immunoblots were then washed in TBST solution at 
least three times at 10 minute intervals. Detection of probes that were bound to 
the proteins of interest was carried out using SuperSignal West Dura Extended 
Duration Substrate (Thermo Scientific, Cat..#34076) chemiluminescence. The 
PVDF membrane was incubated with the substrate for 5 minutes at room 
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temperature and chemiluminescence was then detected by exposure on 
photographic film.           
Assessment of Infarct Size 
 After Langendorff-perfusion, the heart was removed from the cannula, 
wrapped in clear Saran wrap and placed at -20oC for 1-2 hours. The Saran wrap 
was used to prevent tissue damage during freezing. Once the tissue was solid, it 
was sliced using a slicing block fitted with 10 razor blades separated at 1mm 
intervals to obtain cardiac slices of equal thickness. The slices were then 
incubated in tetrazolium stain (composed of 1% solution of 2,3,5-triphenyl 
tetrazolium chloride (TTC) in phosphate buffered pH to 7.4) for 15-20 minutes at 
a temperature of 37oC. The slices were agitated at least once a minute to evenly 
stain all sides. Once a red color had been established (TTC stains viable tissue 
red), the slices were fixed in 10% formaldehyde for about 20 minutes at room 
temperature before they were placed at 4oC overnight to improve contrast 
between the stained and unstained tissue. Infarcted tissue was not stained by 
TTC and remained a pale tan color. Slices were placed between two glass slides 
and imaged using a stereo microscope at 1.0x magnification and a CCD camera. 
(Methods used for infarct size quantification are described later).  
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Antibodies Used 
 All our antibodies used in Western blotting were either produced in our 
laboratory or bought commercially. All of our secondary antibodies were 
conjugated with Horseradish Peroxidase (HRP) for detection (See Table 2). The 
Kir6.2 antibodies were tested for experimental optimization of mouse tissue 
samples. 
Primary 
Antibodies 
Clone/
Name 
Spec. Source Cat. No. Dilution 
(WB) 
Kir6.2 
 
G-16 Goat Santa-Cruz 
Biotechnology 
#sc-1228 1:1,000 
C-62 Chicken Developed in Lab  1:200 
W62b Rabbit Developed in Lab  1:1,000 
N-18 Goat Santa-Cruz 
Biotechnology 
#sc-1226 1:200 
SUR2A M-19 Goat Santa-Cruz 
Biotechnology 
#sc-32462 1:200 
 
Secondary 
Antibodies 
Clone/
Name 
Spec. Source Cat. No. Immunoflu
orescence 
(WB) 
goat anti-rabbit 
IgG-HRP 
 Goat Santa-Cruz 
Biotechnology 
#sc-2004 1:50,000 
donkey anti-goat 
IgG-HRP 
 Donkey Santa-Cruz 
Biotechnology 
#sc-2020 1:10,000 
Peroxidase-
conjugated 
AffiniPure 
Donkey Anti-
Chicken IgY 
 Donkey Jackson 
ImmunoResearch 
lot#57686 1:10,000 
 
Table 2. Antibodies 
Primary and secondary antibodies used for immunoblotting. Clone name, species, source, 
catalog number, and dilution ratios used are listed.       
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Data Analysis 
 Quantification of immunoblots was performed using ImageJ (version 
1.4.3.67 National Institute of Health, USA), which detected the density of pixels of 
the band of interest on the scanned immunoblots and provided densitometry 
graphs for each band. The areas under the resulting peaks were calculated and 
used to represent band intensities. Band intensities were averaged and data was 
graphed using OriginPro Version 8 (OriginLab Corporation, Northampton, 
Massachusetts).  
Analysis of the infarct sizes induced in heart slices were done by 
calculating the percentage of infarcted tissue relative to total tissue sample. This 
was determined using a custom MATLAB (Mathworks, Inc, Natick, 
Massachusetts) program written by Dr. Coetzee, which analyzes infarct size 
based on RGB coloring of image. Using searching routines and contrast 
detection, it automatically detects all infarcted portions of heart in the green 
channel and all non-infarcted portions of heart in the red channel of the RGB 
image. This information is used to calculate the heart size, the infarct size, and 
the percentage of the infarct as a function of total heart size.  
Data are presented as means + SEM when more than three samples were 
tested. Statistical analysis was done with SigmaPlot 11.0 (Systat Software, Inc, 
San Jose, California). The Student’s t-test and one way ANOVA were used to 
test statistical significance, which was denoted with an asterisk if p<0.05.  
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RESULTS 
Resource Development 
Characterization of Antibodies 
 There are several antibodies that are available to detect Kir6.2 subunit of 
the KATP channel protein. In order to ensure that we could reliably detect the 
protein with high specificity in immunoblotting, we carried out tests to determine 
the best antibody that could be used. In our testing we used samples from mouse 
brain and heart. The antibodies tested were C-62, G-16, W62b, (Kefaloyianni et 
al., 2013 ) and N-18 (Ploug, Edvinsson, Olesen, & Jansen-Olesen, 2006) as they 
have been successfully used previously. Since these antibodies weren’t 
previously characterized on mouse tissue samples, it was important to determine 
the optimal antibody for protein detection in subsequent experiments. We used 
tissues from cardiac specific conditional knockout mice to test the antibodies. 
Knockout of Kcnj11—the gene for Kir6.2 protein—was induced by tamoxifen 
treatment. Intraperitoneal injections were given for 5 consecutive days and the 
mice were studied 6 weeks after tamoxifen induction. Hearts and brains were 
isolated from induced and non-induced mice (non-induced mice were injected 
with corn oil instead of tamoxifen) and membranes were prepared as described 
in the Methods section. The resulting proteins were subjected to Western blotting 
with 40 μg protein per lane. Kir6.2 has been shown to migrate as a ~37 kDa 
(Morrissey et al., 2005). Since the gene knockout is specific to the cardiac tissue, 
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we expected to see a band with reduced intensity in the induced heart samples 
when compared to the brain and non-induced heart samples. 
Testing of C-62 and G-16 was inconclusive as Kir6.2 was not readily 
detected in our specific conditions and dilutions (Figure 1A and 1B). Reasons for 
this negative result are not clear, since these antibodies have previously been 
used to specifically detect Kir6.2 in mouse (Kefaloyianni et al., 2013). The 
immunoblot for W62b testing showed that, despite the presence of multiple non-
specific bands, this antibody detected a band at ~37 kDa, which was less 
prominent in the cardiac-specific Kir6.2 knockout mouse heart (Figure 1C). The 
faint band in lanes corresponding to knockout mice tissue most likely represents 
incomplete Kir6.2 excision. Testing the N-18 antibody showed similar results as 
W62b. Band intensities were decreased in induced heart samples as compared 
to non-induced heart and brain samples.  
Following these tests, we concluded that W62b and N-18 were the most 
reliable antibodies for detection of Kir6.2. They both showed bands at ~37 kDa 
where Kir6.2 is known to be detected and demonstrated decreased intensity in 
Kir6.2 knockout mice. In all subsequent tests in which Kir6.2 detection was 
needed, either the W62b antibody or the N-18 antibody was used.   
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Figure 1. Characterization of Anti-Kir6.2 Antibodies in Membrane Preparations 
Immunoblots of mouse heart and brain membrane preparations are shown. 40 μg of protein was 
subjected to a 10% SDS-PAGE. Lanes labeled CH corresponds to control heart, IH corresponds 
to induced heart, CB corresponds to control brain, and IB corresponds to induced brain. (A) 
Immunoblotting was performed using C-62 at a dilution of 1:200. Secondary antibody of 
peroxidase-conjugated donkey anti-chicken IgY diluted to 1:10,000 was used. (B) Immunoblotting 
was performed using G-16 at a dilution of 1:1000. Secondary antibody of donkey anti-goat IgG-
HRP diluted to 1:10,000 was used. (C)  Immunoblotting was performed using W62b at a dilution 
of 1:1000. Secondary antibody of goat anti-rabbit IgG-HRP diluted to 1:50,000 was used. (D) 
Immunoblotting was performed using N-18 at a dilution of 1:200. Secondary antibody of donkey 
anti-goat IgG-HRP diluted to 1:10,000 was used.        
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Effect of Salt and Urea Concentration on Membrane Preparations 
 Since membrane preparation procedure involves two centrifugation steps, 
as previously described, the possibility existed that some of the protein of interest 
was lost when discarding the first insoluble pellet after the first 4000g 
centrifugation step. This possibility is especially likely to occur because KATP 
channel subunits are associated with the cytoskeleton (Brady, Alekseev, 
Aleksandrova, Gomez, & Terzic, 1996). It is possible to disrupt the interaction 
between proteins and the cytoskeleton with high sodium chloride (NaCl) 
concentrations, which breaks electrostatic interactions and hydrogen bonding 
(Patton, Dhanak, & Jacobson, 1989). Other chaotropes such as urea or low pH 
have also been used for this purpose (Garewal & Wasserman, 1974).  
We investigated whether varying the salt concentrations in HM would 
improve Kir6.2 protein extraction in membrane preparations. To do this, we 
added various NaCl and urea concentrations to the membrane preparations to 
see which, if any, could improve protein yield (Figure 2).  
All hearts were perfused for 45 minutes before being flash frozen with 
liquid nitrogen and used for membrane preparation. In control hearts, no salt or 
urea was added to the complete HM during homogenization. In test conditions 
examining the effect of salt concentrations, we added 0.15M, 0.25M, or 0.50M 
NaCl to the HM. In urea tests, we added either 2M or 4M urea to the HM in the 
absence of NaCl before homogenization. We then carried out crude membrane 
preparation and tested by immunoblotting the pellets, after the first and second 
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centrifugation steps, for Kir6.2. As demonstrated by the blot in figure 2, in control 
conditions, much of the protein was left in the pellet after the first centrifugation 
step (which is normally discarded). Addition of increasing NaCl concentrations 
made a major difference in robust protein extraction. The amount of protein 
recovered (e.g. lane 2 relative to lane 1) was greatest when 0.50M NaCl was 
present in the HM. In the urea test, addition of 2M urea was most effective in 
protein extraction, as the darkest band was detected at that concentration. When 
we compare lanes 1 and 2 from the 2M urea test to lanes 1 and 2 from the 
control, a significant increase in protein recovery can be observed. We concluded 
that the use of 0.50M NaCl or 2M urea improves membrane protein extraction. 
         
 
 
Figure 2. Various NaCl and Urea Concentration Test 
All lanes denoted with “1” correspond to insoluble fraction after the first centrifugation in crude 
membrane preparation. All lanes denoted with “2” correspond to membrane fraction after second 
centrifugation. Standard complete HM solution as described in methods was used for control. Salt 
concentrations added to complete HM were 0.15M, 0.25M, and 0.50M NaCl. Urea was added 
with no salt, in concentrations of 2M and 4M to complete HM. Immunoblot was probed for anti-
Kir6.2 (W62b, primary dilution of 1:1000 and secondary of anti-rabbit diluted to 1:50,000).  
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Effect of Non-Heating vs. Heating of Samples 
Antibodies typically recognize a small portion of the protein of interest 
(referred to as the epitope) and this domain may reside within the three 
dimensional conformation of the protein. To enable access of the antibody to this 
portion it is necessary to unfold the protein, i.e. denature it by boiling the protein 
samples prior to gel loading. When investigating KATP channel subunits, samples 
are not boiled, because of the fact that KATP channel subunits are 
transmembrane proteins and they are hydrophobic (Kaufman, Krangel, & 
Strominger, 1984) and boiling tends to cause protein aggregation which is 
detrimental for resolution on the gel. We hypothesized that perhaps heating the 
samples at a lower temperature like 37ºC for 10 minutes, instead of high 
temperature, might aid in better protein detection without forming protein 
aggregates. 
 To test this hypothesis, we heated one set of protein samples and the 
control protein samples were at room temperature. Normally, Kir6.2 is detected 
less in the sarcolemmal fraction than the endosomal fraction. This was also true 
for the heated and control test scenarios. However, the heated samples seemed 
to show better detection of the protein of interest in lanes corresponding to both 
fractions (Figure 3). From this test, we concluded that heating samples to 37o C 
was beneficial for better protein detection. 
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Figure 3. Non-Heating vs. Heating of Samples 
Samples in the left two lanes were not heated and samples in the right two lanes were heated to 
37
o
C for 10 minutes prior to loading. W62b was used to detect Kir6.2 in samples in primary 
dilution of 1:1000 and secondary anti-rabbit dilution of 1:50,000. SL – sarcolemmal fraction; 
ENDO – endosomal fraction.  
 
Translocation of KATP Channel Proteins during Ischemia 
 Preliminary data on isolated mouse hearts from the Coetzee Lab 
(unpublished) suggested that there is a shift in KATP channel distribution from the 
sarcolemma to the endosomes during ischemia. Based on these observations, 
we hypothesized that KATP channels are internalized to the endosomes during 
ischemia and redistributed back to the sarcolemma during ischemic pre-
conditioning. These experiments were performed by using Krebs Henseleit 
Langendorff-perfused mouse hearts and two groups were investigated. In the no-
ischemia (control) group, hearts were continuously perfused at normoxic 
conditions for 75 minutes before tissue was harvested for biochemical separation 
of membrane fractions or determination of infarct size. In the ischemia group, 
hearts were stabilized by perfusing for 45 minutes, followed by a 30 min ischemic 
period before tissue was harvested (Table 1). We found that ischemia was 
associated with a significant increase in infarct size (2 ± 0.46 % in control hearts 
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vs 30 ± 0.57 % in the ischemia group; n=4, p=0.033). Concomitantly, we found 
that KATP channels are internalized during ischemia. This was shown by the 
immunoblot shown in Figure 4A, as tissue from the control group had similar 
Kir6.2 band intensities in the sarcolemmal and endosomal fractions, whereas the 
Kir6.2 band was less prominent in the sarcolemmal fraction relative to the 
endosomal fraction in the heart that was subjected to 30 min ischemia. 
Quantitative analysis confirmed this assessment (Figure 4B). The band 
intensities in the sarcolemmal and endosomal fractions were quantified using 
ImageJ (see Methods section) and expressed relative to the band intensities of 
the total protein (sarcolemmal fraction plus the endosomal fraction). This analysis 
demonstrated that there was significantly less Kir6.2 KATP channel subunits in the 
sarcolemma of the ischemic heart compared to the control heart. In the control 
heart, 59 ± 5.3% (n=4) of Kir6.2 was in the sarcolemmal fraction, whereas 39 ± 
4.9% (n=4, p=0.033 Student’s t-test) of Kir6.2 subunits were present in the 
sarcolemmal fraction of the ischemic heart. This result confirmed that KATP 
channels are internalized during ischemia and that the sarcolemmal fraction of 
KATP channels decreases.  
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A) W62b Antibody 
 
 
B) 
 
Figure 4. Ischemia Reduces the Amount of Kir6.2 protein in the Sarcolemmal Fractions of 
Mouse Hearts 
Hearts were subject to 75 minutes of perfusion (Control) or 45 minutes of stabilization followed by 
30 minutes of ischemia (Ischemia). (A) Immunoblot of protein samples. W62b antibody was used 
for detection of Kir6.2 subunit in protein sample. (B) Quantitative analysis of sarcolemmal KATP 
channel density compared to total protein (sarcolemmal plus endosomal fractions) in control and 
ischemic hearts. (n=4) p =0.033, Student’s t-test. SL – sarcolemmal fraction; ENDO – endosomal 
fraction. 
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Reperfusion 
 It has previously been demonstrated that reperfusion of the heart after an 
ischemic event may be detrimental due to the generation of reactive oxygen 
species (ROS) and intracellular calcium overload. In our experiments, we 
investigated the effects of reperfusion following an ischemic event on KATP 
channel subcellular trafficking. Hearts were Langendorff-perfused (as described 
previously) and were subjected to 30 min ischemia followed by either 15 min or 
30 min reperfusion. We prepared sarcolemmal and endosomal fractions from 
each heart and performed SDS-PAGE electrophoresis followed by 
immunoblotting with a Kir6.2 antibody (W62b). As previously demonstrated 
(Figure 4A), ischemia decreased the amount of Kir6.2 in the lanes of the 
immunoblot corresponding to the sarcolemmal fraction (Figure 5A). Reperfusion 
led to an increase of the Kir6.2 protein in these lanes. Increasing the reperfusion 
time from 15 to 30 min led to additional recovery of Kir6.2 in the sarcolemmal 
fractions (Figure 5C). To confirm that our observations were indeed true for the 
studying of the KATP channel, we probed the membrane with an SUR2A antibody, 
M-19. This experiment confirmed that sarcolemmal density of KATP channel 
protein was decreased by ischemia and that it recovered during reperfusion in a 
time dependent manner (Figure 5C). There was a discrepancy in the band 
intensities of different lanes compared to those of the W62b blot. This may be 
due to the loss of protein during the stripping process, but as can be seen, the 
same pattern was produced when tracking SUR2A changes. This analysis also 
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showed that KATP channels traffic together as a complete unit rather than 
individual subunits, as both subunits demonstrated the same pattern. 
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A) W62b Antibody 
 
B) M-19 Antibody 
 
C) 
 
Figure 5. Effects of Reperfusion on KATP Channel Trafficking 
Control hearts were perfused for 45 minutes. Ischemic hearts were perfused for 15 minutes for 
stabilization followed by 30 minutes of Ischemia. R15 – Stabilization for 15 minutes followed by 
30 minutes of ischemia and 15 minutes of reperfusion. R30 – Same condition as R15 but with 30 
minutes of reperfusion following ischemia instead of 15 minutes. (A) Testing with W62b antibody 
with dilutions as mention in previous figures. (B) Immunoblotting was performed using M-19 at a 
dilution of 1:200. Secondary antibody of donkey anti-goat IgG-HRP diluted to 1:10,000 was used. 
(C) Quantitative analysis of KATP channel surface density with Kir6.2 testing compared with 
SUR2A testing. Blue is W62b antibody and yellow is M-19 antibody. 
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Ischemic Preconditioning 
 Next, we investigated the effect of IPC on the trafficking of KATP channel. 
This was done by subjecting isolated, Langendorff-perfused mouse hearts to an 
IPC protocol consisting of a 15 min stabilization period, followed by three periods 
of 5 min of ischemia with 5 min reperfusion, and then followed by 30 min of 
ischemia (75 min total). We also included ‘no-ischemia’ (control) group, which 
were normoxically perfused for a period of 75 min, as well as an ‘ischemia’ 
group, which consisted of a 45 min stabilization period, followed by 30 min 
ischemia. Hearts were harvested, sarcolemmal (SL) and endosomal (Endo) 
fractions were prepared and immunoblotting was performed to detect Kir6.2 
protein in the various fractions.  
 Consistent with our prior findings (Figures 4 and 5), the amount of Kir6.2 
in the SL fraction was decreased by ischemia. In hearts subjected to the IPC, 
however, this ischemia-induced decrease of Kir6.2 in the SL fraction was not 
observed (Figure 6A). Thus, it appears that IPC by itself either increases the SL 
KATP channel density or that IPC prevents the ischemia-induced KATP channel 
internalization.  
To distinguish between these possibilities, we examined hearts that were 
normoxically perfused for 75 min in the absence of ischemia, and hearts that 
were subjected to the IPC protocol, but without the subsequent 30 min ischemic 
period. From these experiments, we found that IPC in the absence of ischemia 
did not increase the amount of SL Kir6.2 protein, suggesting therefore that IPC 
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by itself does not increase the SL KATP channel density (See Figure 7). 
Therefore, we conclude that IPC prevents the KATP channel internalization that 
has been shown to occur during ischemia.  
A)  W62b Antibody 
 
B) W62b Antibody 
 
C) 
 
Figure 6. IPC and Adenosine Preconditioning  
Control hearts were perfused for 75 minutes. Ischemic hearts were perfused for 45 minutes for 
stabilization followed by 30 minutes of ischemia. (A) IPC hearts had 15 minutes of stabilization 
followed by 5 minutes of ischemia and 5 minutes of reperfusion (repeated 3 times for a total of 30 
minutes), followed by 30 minutes of ischemia. Immunoblot was tested with W62b antibody. (B) 
Adenosine hearts were perfused for 45 minutes with KH buffer + 100 mM adenosine followed by 
30 minutes of ischemia. (C) Quantitative analysis for KATP channels in sarcolemma compared to 
total protein. (n=4). Control vs. Ischemia (* p=0.005). Ischemia vs. IPC (** p=0.022). One way 
ANOVA. 
 34 
Pharmacological Preconditioning  
 Next we examined the effect of pharmacological preconditioning (PPC) on 
KATP channel trafficking. For these experiments we used adenosine, which is a 
known endogenous cardioprotective agent. Early work by the Downey group, for 
example, showed that pre-perfusion of hearts with adenosine afforded the same 
protective effects against an ischemic event as found with IPC perfusion 
protocols (Liu & Downey, 1992). To examine effects on KATP channel trafficking, 
we subjected isolated, perfused mouse hearts to a PPC protocol, consisting of a 
45 min stabilization period with KH solution (with or without 100 µM adenosine), 
followed by a 30 min ischemic period. These hearts were compared to an 
‘ischemia’ group, consisting of a 45 min stabilization period with KH solution 
(without adenosine), followed by a 30 min ischemic period. As before, hearts 
were harvested at the end of the experiment and analyzed for the presence of 
KATP channel subunits in biochemically prepared SL and Endosomal membrane 
fractions.  
Compared to the ‘no-ischemia’ (control) group, ischemia led to an 
internalization of KATP channels from the SL to the Endo membrane fractions 
(Figure 6A; see also Figure 6B). In the PPC group, however, the ischemia-
induced Kir6.2 Internalization was prevented (Figure 6B,C). Thus, PPC with 
adenosine had the same effect on KATP channel trafficking patterns as observed 
with IPC. 
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 We performed a quantitative analysis for each condition (Figure 6C). In 
the control heart, 59 ± 5.3% (n=4) of Kir6.2 was in the sarcolemmal fraction 
whereas 34 ± 2.2% of the Kir6.2 subunits were present in the sarcolemmal 
fraction in ischemic heart. In the IPC heart, 52 ± 3.9% (n=4) of Kir6.2 was in the 
sarcolemmal fraction.  A one way ANOVA was performed and it was statistically 
significant between the control and ischemic groups with a p value of 0.005 and 
between ischemic and IPC groups with a p=0.022. 
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A) W62b Antibody 
 
B) 
 
 
Figure 7. Control vs. IPC without Ischemia 
Hearts were perfused for 75 minutes under control conditions. In IPC, hearts were perfused for 15 
minutes following 5 minutes of ischemia and 5 minutes of stabilization (x3) followed by 30 
minutes of reperfusion. (A) Immunoblot of protein samples. (B) Quantification of protein samples. 
SL – sarcolemmal fraction; ENDO – endosomal fraction   
 
  
  IPC 
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Effects of Ischemia and IPC on Myocardial Infarction 
 In our final test, we sought to determine the effect of ischemia, IPC and 
PPC on infarct sizes of isolated Langendorff-perfused mouse hearts. We wanted 
to determine if preconditioning prevented myocardial damage due to ischemia as 
has been previously described (Murry et al., 1986). The perfusion protocols were 
identical to those used in the previous sections (see also Table 1). At the end of 
each experiment, hearts were removed from the perfusion cannula, sliced to 
1mm thicknesses and subjected to TTC staining to determine the infarct size 
(see Methods for details). Pericardial infarcted zones were identified as the tissue 
that was not stained red with TTC (the tan ring at the edge of the heart) (See 
Figure 8Ab). In the no-ischemia group, infarction was not detected (Figure 8Aa). 
In ischemic hearts, those subjected to IPC, and in adenosine induced PPC 
hearts, infarcted tissue was evident (Figure 8Ab, 8Ac and Figure 8Ad), but 
appeared to be less pronounced in IPC and PPC hearts than with the ischemic 
heart. We quantitatively measured the infarct size (as a percentage of the whole 
heart) from digitized images using custom software (Figure 8B). This analysis 
showed that infarction was absent in control hearts and that ischemia produced 
an infarct size of 30.0 ± 0.57% (n=7). Both IPC and adenosine-induced PPC 
reduced the infarct size, to 6.6 ± 1.28% (n=7, p<0.001) and 7.3 ± 0.87% (n=9, 
p<0.001) respectively. The statistical testing was performed using a one way 
ANOVA. 
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A) 
 
B) 
 
Figure 8. IPC and Adenosine-induced PPC Reduce Myocardial Infarction caused by 
Ischemia in Isolated, Perfused Mouse Hearts 
Hearts were measured for infarct sizes following various conditions. All pictures chosen were 
representative of the group. Aa) Control hearts. Ab) Ischemic hearts. Ac) IPC heart. Ad) 
Adenosine treated hearts. B) Percent of infarction compared to the heart as a whole. Control vs. 
Ischemia (* p<0.001). Ischemia vs. IPC (** p<0.001). Ischemia vs. Adenosine (***p<0.001). One 
way ANOVA. 
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DISCUSSION 
 
 Cellular studies have shown that trafficking to the sarcolemma and 
increasing the surface density of KATP channels may be a mechanism of the 
cardioprotection observed with IPC or PPC (Turrell et al., 2011). This has not 
been demonstrated in intact hearts. We had similar data, but our study suggests 
an alternative interpretation. We find that KATP channels are internalized during 
ischemia, and that IPC prevents this internalization. Our study is the first to 
demonstrate KATP channel trafficking between sarcolemmal and endosomal 
compartments in intact hearts, and that this translocation of KATP channel 
correlates with cardioprotection.  
We demonstrate that KATP channels are endocytosed during ischemia, and 
that IPC either prevents this endocytosis. We also showed that reperfusion 
causes the trafficking of channels from the endosomal compartment to the 
sarcolemma, providing a cardioprotective effect. An increased surface ATP-
sensitive potassium channel density is expected to be protective because they 
limit excitation and prevent Ca2+ influx, thereby preventing cytosolic Ca2+ 
overload, mitochondrial damage, necrosis and arrhythmias. Since trafficking 
plays a very important role in distribution of the channel among the endosomal 
and sarcolemmal compartments of the cell, further tests should be carried out to 
better establish the trafficking pathway of KATP channels. 
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Ischemia and KATP Channels 
Our data shows that ischemia causes internalization of KATP channels, 
most likely through endocytosis (Figure 4). This was a different result than some 
previous reports (Edwards et al., 2009. and Bao, Hadjiolova, Coetzee, & Rindler, 
2011), which demonstrated an increased sarcolemmal KATP channel density with 
ischemia. A possible cause of this discrepancy is the fact that we used mouse 
hearts, whereas other studies were performed with rat hearts or in vitro. It is also 
important to note that the protocol for ischemia might be different, causing 
varying results. A standard procedure is needed to further test if KATP channels 
are endocytosed or move to the surface in ischemia. This could possibly be done 
by testing sarcolemmal and endosomal fractions after various ischemic time 
points. However, we demonstrated that there is an inner reservoir of KATP 
channels that can be trafficked in or out of the endosomal compartments (Figure 
5). 
IPC and KATP Channels 
Using cardiac specific Kir6.2 knockout mice, studies have shown KATP 
channels to play a major role in IPC induced cardioprotection (Suzuki et al., 2002 
and Suzuki et al., 2003) and that IPC is cardioprotective by increasing opening of 
KATP channels at the surface (Jerome et al., 1995 and Schultz et al., 1997). Thus, 
the surface KATP channel density is expected to directly correlate with the degree 
of IPC-induced cardioprotection. We have shown that IPC increases the surface 
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density of KATP channels. We have further shown that a pharmacological form of 
preconditioning—the addition of adenosine—results in the same trafficking 
pattern as IPC and may be a cause of its cardioprotection (Figure 6B and 8Ad). 
In future studies, it will be imperative to develop a more targeted form of 
pharmacological preconditioning. This is because most current pharmacological 
preconditioning results in the movement of all KATP channels, including 
mitochondrial KATP channels, to the membrane rather than just sarcolemmal 
channels.  
Future Directions 
Finally, once we have fully established that KATP channels are trafficked 
between the membrane fractions, it would be essential to determine the signaling 
pathways involved. It has been previously documented that pharmacological 
preconditioning in myocardial cells led to an increased surface density and this 
effect was mediated by a PKCε/AMPK signaling pathway (Turrell et al., 2011). 
Hypoxic preconditioning was also reported to increase the surface KATP channel 
density of cardiomyocytes (Budas et al., 2004), but the underlying signaling 
mechanisms were not investigated. Further studies need to be carried out to 
delineate the signaling mechanisms involving PKC, AMPK and their downstream 
effectors and their roles in preconditioning. 
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